Total Payments
$78,744
2021 Payments
$23.44
Companies
5
Transactions
36
Medicare Patients
232
Medicare Billing
$1.2M
Payment Breakdown by Category
Consulting$78,280 (99.4%)
Travel$304.20 (0.4%)
Food & Beverage$159.76 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $78,280 | 27 | 99.4% |
| Travel and Lodging | $304.20 | 1 | 0.4% |
| Food and Beverage | $159.76 | 8 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| HOSPIRA, INC. | $78,584 | 28 | $0 (2017) |
| Novo Nordisk Inc | $58.24 | 3 | $0 (2021) |
| Medtronic MiniMed, Inc. | $55.32 | 2 | $0 (2019) |
| Amgen Inc. | $30.65 | 2 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.55 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $23.44 | 1 | Novo Nordisk Inc ($23.44) |
| 2020 | $17.53 | 1 | Novo Nordisk Inc ($17.53) |
| 2019 | $66.24 | 3 | Medtronic MiniMed, Inc. ($35.59) |
| 2018 | $19.73 | 1 | Medtronic MiniMed, Inc. ($19.73) |
| 2017 | $78,617 | 30 | HOSPIRA, INC. ($78,584) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/21/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Diabetes | ||||||
| 02/12/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Obesity | ||||||
| 12/27/2019 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $35.59 | General |
| Category: Durable Pump | ||||||
| 11/18/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Cardiology | ||||||
| 08/26/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Cardiology | ||||||
| 01/12/2018 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Durable Pump | ||||||
| 06/29/2017 | HOSPIRA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 06/22/2017 | HOSPIRA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 06/15/2017 | HOSPIRA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 06/08/2017 | HOSPIRA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 06/01/2017 | HOSPIRA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 05/25/2017 | HOSPIRA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 05/24/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Diabetes | ||||||
| 05/18/2017 | HOSPIRA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 05/15/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: DIABETES | ||||||
| 05/11/2017 | HOSPIRA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 05/04/2017 | HOSPIRA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 04/27/2017 | HOSPIRA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 04/20/2017 | HOSPIRA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 04/13/2017 | HOSPIRA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 04/06/2017 | HOSPIRA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 03/30/2017 | HOSPIRA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 03/23/2017 | HOSPIRA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 03/16/2017 | HOSPIRA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| 03/09/2017 | HOSPIRA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 93 | 1,187 | $2.0M | $453,962 |
| 2022 | 5 | 77 | 897 | $1.6M | $462,488 |
| 2021 | 4 | 51 | 651 | $1.1M | $326,461 |
| 2020 | 1 | 11 | 11 | $6,490 | $1,610 |
Total Patients
232
Total Services
2,746
Medicare Billing
$1.2M
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77605 | Use of externally generated heat to increase temperature of cancer cell, heating to depths more than 4.0 cm | Office | 2023 | 19 | 425 | $1.5M | $336,628 | 22.7% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 19 | 443 | $412,072 | $97,551 | 23.7% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 16 | 76 | $47,424 | $12,419 | 26.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 19 | 223 | $17,960 | $4,646 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $11,705 | $2,718 | 23.2% |
| 77605 | Use of externally generated heat to increase temperature of cancer cell, heating to depths more than 4.0 cm | Office | 2022 | 14 | 378 | $1.2M | $345,932 | 29.7% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2022 | 14 | 417 | $414,127 | $100,946 | 24.4% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2022 | 12 | 65 | $42,651 | $10,681 | 25.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $15,097 | $3,494 | 23.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 13 | 13 | $8,467 | $1,435 | 16.9% |
| 77605 | External hyperthermia treatment depth greater than 4 cm | Office | 2021 | 12 | 258 | $709,104 | $234,519 | 33.1% |
| 77280 | Management of radiation therapy simulation, simple | Office | 2021 | 12 | 340 | $330,764 | $83,434 | 25.2% |
| 77427 | Radiation treatment management, 5 treatments | Office | 2021 | 12 | 38 | $25,650 | $6,291 | 24.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $8,850 | $2,217 | 25.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $6,490 | $1,610 | 24.8% |
About Dr. Joseph Pinzone, M.D
Dr. Joseph Pinzone, M.D is a Medical Oncology healthcare provider based in Thousand Oaks, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700893815.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Pinzone, M.D has received a total of $78,744 in payments from pharmaceutical and medical device companies, with $23.44 received in 2021. These payments were reported across 36 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($78,280).
As a Medicare-enrolled provider, Pinzone has provided services to 232 Medicare beneficiaries, totaling 2,746 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Other Specialties Diabetes & Metabolism
- Location Thousand Oaks, CA
- Active Since 08/02/2006
- Last Updated 03/11/2025
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1700893815
Products in Payments
- Minimed 670G System (Device) $55.32
- Ozempic (Drug) $23.44
- Saxenda (Drug) $17.53
- Victoza (Drug) $17.27
- Repatha (Biological) $16.73
- JARDIANCE (Drug) $15.55
- Corlanor (Drug) $13.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Thousand Oaks
Dr. Ashwin Kashyap, M.d, M.D
Medical Oncology — Payments: $10,588
Medical Oncology $10,588
Bassam Ghanem, Md, MD
Medical Oncology — Payments: $9,037
Medical Oncology $9,037
Dr. Bahareh Bahadini, Md, MD
Medical Oncology — Payments: $3,239
Medical Oncology $3,239
Dr. Jeffrey Wiezorek
Medical Oncology
Medical Oncology